Trial Profile

a Phase 1 clinical study of TK-6302

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 02 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TK 6302 (Primary)
Indications Solid tumours
Focus Adverse reactions
Sponsors T-Knife

Most Recent Events

25 Apr 2025 According to the T-knife Media Release, company plans to submit a Clinical Trial Application (CTA) in fourth quarter of 2025 and to initiate a Phase 1 clinical study of TK-6302 in early 2026.
26 Mar 2025 New trial record
25 Mar 2025 According to the T-knife Media Release, company plans to submit a Clinical Trial Application (CTA) in the fall of 2025 to initiate a Phase 1 clinical study of TK-6302 in 2026.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com